Browse by Journal Title

2016

Benefits and risks of aliskiren treatment in patients with type 2 diabetes: analyses of the 3A registry.
Kistner, I. and Zeymer, U. and Dechend, R. and Hagedorn, I. and Riemer, T. and Bramlage, P. and Pittrow, D. and Senges, J. and Schmieder, R.E.
Journal of Clinical Hypertension 18 (10): 1045-1053. October 2016

Two-year outcomes of patients treated with aliskiren under clinical practice conditions: non-interventional prospective study.
Zeymer, U. and Dechend, R. and Riemer, T. and Deeg, E. and Senges, J. and Pittrow, D. and Schmieder, R.
Journal of Clinical Hypertension 18 (7): 647-654. July 2016

2012

Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.
Dechend, R. and Kaiser, E. and Derer, W. and Deeg, E. and Busjahn, A. and Schmieder, R.E. and Zeymer, U.
Journal of Clinical Hypertension 14 (8): 496-501. August 2012

2002

Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension.
Jordan, J. and Biaggioni, I.
Journal of Clinical Hypertension 4 (2): 139-145. March 2002